标题
Immunotherapies and immunomodulatory approaches in clinical trials - a mini review
作者
关键词
-
出版物
Human Vaccines & Immunotherapeutics
Volume -, Issue -, Pages 1-13
出版商
Informa UK Limited
发表日期
2021-02-18
DOI
10.1080/21645515.2020.1871295
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A Multicenter Retrospective Analysis of Outcomes and Toxicities with Commercial Axicabtagene Ciloleucel and Tisagenlecleucel for Relapsed/Refractory Aggressive B-Cell Lymphomas
- (2020) Peter A. Riedell et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Emerging coronaviruses: Genome structure, replication, and pathogenesis
- (2020) Yu Chen et al. JOURNAL OF MEDICAL VIROLOGY
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
- (2020) Nanshan Chen et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Convalescent plasma as a potential therapy for COVID-19
- (2020) Long Chen et al. LANCET INFECTIOUS DISEASES
- CAR T-cell product performance in haematological malignancies before and after marketing authorisation
- (2020) Magdi Elsallab et al. LANCET ONCOLOGY
- CAR T cells: continuation in a revolution of immunotherapy
- (2020) Anurag K Singh et al. LANCET ONCOLOGY
- Is COVID-19 receiving ADE from other coronaviruses?
- (2020) Jason A. Tetro MICROBES AND INFECTION
- Pathogenicity and transmissibility of 2019-nCoV—A quick overview and comparison with other emerging viruses
- (2020) Jieliang Chen MICROBES AND INFECTION
- Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
- (2020) Guangdi Li et al. NATURE REVIEWS DRUG DISCOVERY
- Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts’ consensus statement
- (2020) Kunling Shen et al. World Journal of Pediatrics
- Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus
- (2020) Zhi-Min Chen et al. World Journal of Pediatrics
- Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies
- (2020) Syed Faraz Ahmed et al. Viruses-Basel
- Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody
- (2020) Xiaolong Tian et al. Emerging Microbes & Infections
- Therapeutic and triage strategies for 2019 novel coronavirus disease in fever clinics
- (2020) Jinnong Zhang et al. Lancet Respiratory Medicine
- Advancing CAR T-Cell Therapy for Solid Tumors: Lessons Learned from Lymphoma Treatment
- (2020) Aleksei Titov et al. Cancers
- Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools
- (2020) Yajing Fu et al. VIROLOGICA SINICA
- SARS-CoV-2–A Tough Opponent for the Immune System
- (2020) Mahsa Golshani Nasab et al. ARCHIVES OF MEDICAL RESEARCH
- Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review
- (2020) Jaume Alijotas-Reig et al. AUTOIMMUNITY REVIEWS
- Chimeric Antigen Receptor T Cell Therapy During the COVID-19 Pandemic
- (2020) Veronika Bachanova et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
- (2020) Alba Grifoni et al. CELL
- COVID-19 infection: the perspectives on immune responses
- (2020) Yufang Shi et al. CELL DEATH AND DIFFERENTIATION
- Treatment With Convalescent Plasma for Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection
- (2020) Bin Zhang et al. CHEST
- Thymosin alpha 1 (Tα1) reduces the mortality of severe COVID-19 by restoration of lymphocytopenia and reversion of exhausted T cells
- (2020) Yueping Liu et al. CLINICAL INFECTIOUS DISEASES
- COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons
- (2020) Shivraj Hariram Nile et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Prevention and treatment of COVID‐19 disease by controlled modulation of innate immunity
- (2020) Virgil Schijns et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Current Status of Cell-Based Therapies for Respiratory Virus Infections: Applicability to COVID-19
- (2020) Maroun Khoury et al. EUROPEAN RESPIRATORY JOURNAL
- Pharmacological perspective: glycyrrhizin may be an efficacious therapeutic agent for COVID-19
- (2020) Pan Luo et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- The epidemiology, diagnosis and treatment of COVID-19
- (2020) Pan Zhai et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality
- (2020) Chi Zhang et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
- (2020) Chenguang Shen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The convalescent sera option for containing COVID-19
- (2020) Arturo Casadevall et al. JOURNAL OF CLINICAL INVESTIGATION
- Deployment of convalescent plasma for the prevention and treatment of COVID-19
- (2020) Evan M. Bloch et al. JOURNAL OF CLINICAL INVESTIGATION
- The potential chemical structure of anti‐SARS‐CoV‐2 RNA‐dependent RNA polymerase
- (2020) Jrhau Lung et al. JOURNAL OF MEDICAL VIROLOGY
- Consider TLR5 for new therapeutic development against COVID‐19
- (2020) Chiranjib Chakraborty et al. JOURNAL OF MEDICAL VIROLOGY
- Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed
- (2020) Marc Feldmann et al. LANCET
- A review of South Indian medicinal plant has the ability to combat against deadly viruses along with COVID-19?
- (2020) Mani Divya et al. MICROBIAL PATHOGENESIS
- Harnessing innate immunity to eliminate SARS-CoV-2 and ameliorate COVID-19 disease
- (2020) Rachel M. Golonka et al. PHYSIOLOGICAL GENOMICS
- Effectiveness of convalescent plasma therapy in severe COVID-19 patients
- (2020) Kai Duan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Novel Combination of Vitamin C, Curcumin and Glycyrrhizic Acid Potentially Regulates Immune and Inflammatory Response Associated with Coronavirus Infections: A Perspective from System Biology Analysis
- (2020) Liang Chen et al. Nutrients
- COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics
- (2020) Kuldeep Dhama et al. Human Vaccines & Immunotherapeutics
- Therapeutic strategies for critically ill patients with COVID-19
- (2020) Lei Li et al. Annals of Intensive Care
- MSC Therapies for COVID-19: Importance of Patient Coagulopathy, Thromboprophylaxis, Cell Product Quality and Mode of Delivery for Treatment Safety and Efficacy
- (2020) Guido Moll et al. Frontiers in Immunology
- Symptomatic Protective Action of Glycyrrhizin (Licorice) in COVID-19 Infection?
- (2020) Harald Murck Frontiers in Immunology
- Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases
- (2020) Cynthia Liu et al. ACS Central Science
- Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants
- (2020) Muhammad Tahir ul Qamar et al. Journal of Pharmaceutical Analysis
- Harnessing HLA‐E‐restricted CD8 T lymphocytes for adoptive cell therapy of patients with severe COVID‐19
- (2020) Nadia Caccamo et al. BRITISH JOURNAL OF HAEMATOLOGY
- Potential use of turmeric in COVID‐19
- (2020) H. Gupta et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- COVID-19: Immunology and treatment options
- (2020) Susanna Felsenstein et al. CLINICAL IMMUNOLOGY
- Coronavirus Disease 2019–COVID-19
- (2020) Kuldeep Dhama et al. CLINICAL MICROBIOLOGY REVIEWS
- Potential of regulatory T cell-based therapies in the management of severe COVID-19
- (2020) Emmanuel Stephen-Victor et al. EUROPEAN RESPIRATORY JOURNAL
- Antibody-based immunotherapeutics and use of convalescent plasma to counter COVID-19: advances and prospects
- (2020) Khan Sharun et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- COVID 19: a clue from innate immunity
- (2020) Domenico Birra et al. IMMUNOLOGIC RESEARCH
- The possible of immunotherapy for COVID-19: A systematic review
- (2020) Akram AminJafari et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Sars-cov-2 host entry and replication inhibitors from Indian ginseng: an in-silico approach
- (2020) Rupesh V. Chikhale et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Identification of bioactive molecule from Withania somnifera (Ashwagandha) as SARS-CoV-2 main protease inhibitor
- (2020) Manish Kumar Tripathi et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Screening of phytochemical compounds of Tinospora cordifolia for their inhibitory activity on SARS-CoV-2: an in silico study
- (2020) S. Krupanidhi et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Evaluation of green tea polyphenols as novel corona virus (SARS CoV-2) main protease (Mpro) inhibitors – an in silico docking and molecular dynamics simulation study
- (2020) Rajesh Ghosh et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Targeting human TLRs to combat COVID‐19: A solution?
- (2020) Ritwik Patra et al. JOURNAL OF MEDICAL VIROLOGY
- Immune-boosting role of vitamins D, C, E, zinc, selenium and omega-3 fatty acids: could they help against COVID-19?
- (2020) Hira Shakoor et al. MATURITAS
- SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19
- (2020) Julian Braun et al. NATURE
- Immunopathology and immunotherapeutic strategies in severe acute respiratory syndrome coronavirus 2 infection
- (2020) Synat Keam et al. REVIEWS IN MEDICAL VIROLOGY
- COVID-19: A promising cure for the global panic
- (2020) Balachandar Vellingiri et al. SCIENCE OF THE TOTAL ENVIRONMENT
- Ongoing Clinical Trials for the Management of the COVID-19 Pandemic
- (2020) Mark P. Lythgoe et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Natural product-derived phytochemicals as potential agents against coronaviruses: A review
- (2020) Janice S. Mani et al. VIRUS RESEARCH
- COVID-19 - Recent advancements in identifying novel vaccine candidates and current status of upcoming SARS-CoV-2 vaccines
- (2020) Mohd. Iqbal Yatoo et al. Human Vaccines & Immunotherapeutics
- Activation of TLR7 and Innate Immunity as an Efficient Method Against COVID-19 Pandemic: Imiquimod as a Potential Therapy
- (2020) Konstantinos Poulas et al. Frontiers in Immunology
- Flattening the COVID-19 Curve With Natural Killer Cell Based Immunotherapies
- (2020) Marisa Market et al. Frontiers in Immunology
- Immunomodulatory Drugs in the Management of SARS-CoV-2
- (2020) Daniel R. Burrage et al. Frontiers in Immunology
- CAR T-cell treatment during the COVID-19 pandemic: Management strategies and challenges
- (2020) Yongxian Hu et al. Current Research in Translational Medicine
- Ruxolitinib Rapidly Reduces Acute Respiratory Distress Syndrome in COVID-19 Disease. Analysis of Data Collection From RESPIRE Protocol
- (2020) Enrico Capochiani et al. Frontiers in Medicine
- Potential of DNA Intercalating Alkaloids and Other Plant Secondary Metabolites against SARS-CoV-2 Causing COVID-19
- (2020) Michael Wink Diversity-Basel
- Monoclonal antibody as a potential anti-COVID-19
- (2020) Leila Jahanshahlu et al. BIOMEDICINE & PHARMACOTHERAPY
- Imiquimod - A toll like receptor 7 agonist - Is an ideal option for management of COVID 19
- (2020) Athina Angelopoulou et al. ENVIRONMENTAL RESEARCH
- Immunobiology and immunotherapy of COVID‐19: A clinically updated overview
- (2020) Abdolreza Esmaeilzadeh et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
- (2020) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glycyrrhizin: An alternative drug for the treatment of COVID-19 infection and the associated respiratory syndrome?
- (2020) Christian Bailly et al. PHARMACOLOGY & THERAPEUTICS
- SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic
- (2020) Ali A. Rabaan et al. Annals of Clinical Microbiology and Antimicrobials
- COVID-19: benefits and risks of passive immunotherapeutics
- (2020) Ankur Gupta et al. Human Vaccines & Immunotherapeutics
- Friends or foes? The knowns and unknowns of natural killer cell biology in COVID-19 and other coronaviruses in July 2020
- (2020) Cordelia Manickam et al. PLoS Pathogens
- Natural killer cell immunotypes related to COVID-19 disease severity
- (2020) Christopher Maucourant et al. Science Immunology
- Modern management of relapsed and refractory aggressive B-cell lymphoma: A perspective on the current treatment landscape and patient selection for CAR T-cell therapy
- (2019) Veronika Bachanova et al. BLOOD REVIEWS
- Herbal Immunomodulators - A Remedial Panacea for Designing and Developing Effective Drugs and Medicines: Current Scenario and Future Prospects
- (2018) Ruchi Tiwari et al. CURRENT DRUG METABOLISM
- Medicinal and Therapeutic Potential of Herbs and Plant Metabolites / Extracts Countering Viral Pathogens - Current Knowledge and Future Prospects
- (2018) Kuldeep Dhama et al. CURRENT DRUG METABOLISM
- Safety and tolerability of a novel, polyclonal human anti-MERS coronavirus antibody produced from transchromosomic cattle: a phase 1 randomised, double-blind, single-dose-escalation study
- (2018) John H Beigel et al. LANCET INFECTIOUS DISEASES
- Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
- (2018) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- (2018) Stephen J. Schuster et al. NEW ENGLAND JOURNAL OF MEDICINE
- Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
- (2017) Sattva S. Neelapu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivo
- (2016) C.-L. Lu et al. SCIENCE
- Historical review of thymosin α 1 in infectious diseases
- (2015) Roberto Camerini et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Sipuleucel-T for therapy of asymptomatic or minimally symptomatic, castrate-refractory prostate cancer: an update and perspective among other treatments
- (2011) Mayer N Fishman et al. OncoTargets and Therapy
- Sipuleucel-T: Prototype for Development of Anti-tumor Vaccines
- (2011) Estrella Carballido et al. Current Oncology Reports
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search